- Children, the elderly, people with asthma or allergies, and immunocompromised individuals are at significantly higher risk from mold exposure than healthy adults.
- Infants and young children are especially vulnerable because their lungs are still developing and their immune systems have less robust defenses.
- Immunocompromised individuals — including transplant recipients, people on chemotherapy, and those with HIV — face risk of life-threatening invasive fungal infections from molds like Aspergillus.
- Genetic variants in immune response genes (such as those affecting cytokine signaling) can increase mold sensitivity even in otherwise healthy individuals.
- People in all high-risk categories benefit most from mold prevention — moisture control remains the most effective protective strategy.
Mold is ubiquitous in both indoor and outdoor environments. Most healthy adults exposed to typical ambient levels experience no significant health effects. However, certain groups face substantially elevated risk — either because their respiratory or immune systems are more reactive to mold antigens, or because mold can cause infections that an intact immune system would normally prevent. Understanding which populations are at heightened risk is essential for prioritizing mold prevention and remediation efforts.
Children
Children represent one of the highest-risk groups for mold-related respiratory illness. Several factors contribute to this vulnerability:
- Developmental stage: Lung development continues through childhood and into early adolescence. Mold exposure during this critical window is associated with impaired lung function development — effects that may persist into adulthood.
- Breathing rate: Children breathe more air relative to their body weight than adults, resulting in proportionally higher exposures at the same ambient mold concentrations.
- Indoor time: Young children spend more time indoors and in proximity to floors where settled spores concentrate.
- Sensitization risk: Early-life sensitization to mold antigens is associated with increased risk of developing persistent asthma. The WHEEZE study and related cohort research have documented that infant exposure to visible mold in the home predicts childhood asthma diagnosis.
Elderly Individuals
Adults over 65 face elevated mold risk for different reasons than children. Immune function naturally declines with age — a process called immunosenescence — which reduces the efficiency of both innate and adaptive immune responses to fungal antigens. Pre-existing respiratory conditions including COPD, which is highly prevalent in older adults, significantly amplify the impact of mold-related airway inflammation. Additionally, elderly individuals are more likely to live alone and may not notice or report mold growth promptly.
Individuals with Asthma
Asthma and mold exposure have a bidirectional relationship. Mold is both a cause of sensitization (mold exposure can contribute to asthma development in previously non-asthmatic individuals) and a trigger of attacks (in already-sensitized asthmatics, even moderate spore exposure can precipitate acute bronchospasm). Several mold genera are particularly potent asthma triggers: Alternaria alternata, Cladosporium, Aspergillus, and Penicillium. Mold-sensitized asthma tends to be more severe and harder to control than non-sensitized asthma.
Individuals with Allergic Rhinitis and Atopic Conditions
People with existing atopic conditions — including allergic rhinitis (hay fever), atopic dermatitis, and food allergies — are more likely to become sensitized to mold antigens and to experience more severe symptoms upon exposure. The atopic march, in which sensitization to one allergen increases the likelihood of sensitization to others, means that existing allergy sufferers face elevated mold allergy risk. Severe asthma with fungal sensitization (SAFS) is a distinct clinical syndrome describing a subset of asthma patients whose disease is driven primarily by sensitivity to mold species.
Immunocompromised Individuals
This group faces a qualitatively different risk from the others: not just exacerbated respiratory symptoms, but potentially fatal invasive fungal infections. Mold species that are entirely harmless to healthy individuals can be life-threatening in immunocompromised hosts. The most important pathogens in this context are:
- Aspergillus fumigatus — the leading cause of invasive aspergillosis, with mortality rates of 30–90% in high-risk patients
- Mucor and Rhizopus species — causing mucormycosis, a rapidly progressive infection
- Fusarium species — increasingly recognized as a cause of disseminated infection in hematology patients
Categories of immunocompromise that confer the highest mold infection risk include: solid organ transplant recipients on immunosuppression, hematopoietic stem cell transplant recipients, patients with prolonged neutropenia (absolute neutrophil count below 500 cells/μL), patients receiving high-dose corticosteroids, and individuals with advanced HIV disease.
Occupational Exposures
Certain occupations carry substantially elevated mold exposure, putting workers at risk for conditions rarely seen in residential settings. Agricultural workers (particularly those handling grain, hay, or compost) can develop hypersensitivity pneumonitis — an inflammatory lung condition from repeated high-dose fungal antigen inhalation. Construction workers disturbing soil or demolishing water-damaged structures are at risk for Histoplasma and Coccidioides exposure in endemic regions. Healthcare workers, particularly those in buildings with HVAC contamination, are also a recognized at-risk group.
Genetic Susceptibility
Not all individuals in the above risk categories are equally affected, and some individuals not in any risk category experience unexpectedly severe mold reactions. Genetic variation in immune response pathways — including polymorphisms in genes encoding toll-like receptors (TLRs), interleukins, and dectin-1 (a key fungal recognition receptor) — influences individual susceptibility to both mold allergy and invasive fungal infection. Genetic testing for mold susceptibility is not currently part of clinical practice, but research in this area is ongoing.
Frequently Asked Questions
Are children more sensitive to mold than adults?
Yes. Children are more vulnerable to mold for several reasons: their lungs are still developing, they breathe more air per unit of body weight, they spend more time indoors, and early-life sensitization to mold antigens predicts long-term respiratory disease. Mold exposure in the home during infancy and early childhood is one of the most consistent predictors of childhood asthma development in epidemiological research.
Can mold kill immunocompromised patients?
Yes. Invasive aspergillosis — caused by inhaling Aspergillus spores that are harmless to healthy people — carries mortality rates of 30–90% in severely immunocompromised patients such as bone marrow transplant recipients with prolonged neutropenia. This is why hematology and transplant units have strict infection control protocols around air filtration and mold prevention.
What mold species are most dangerous for people with asthma?
The mold species most consistently linked to asthma exacerbations are Alternaria alternata, Cladosporium herbarum, Aspergillus fumigatus, and various Penicillium species. Alternaria sensitization in particular is strongly associated with severe asthma and emergency department visits, especially during periods of high outdoor spore counts in late summer and autumn.
Should high-risk individuals move out of a moldy home?
For severely immunocompromised individuals (such as those undergoing bone marrow transplantation), temporary relocation during active mold remediation is often medically recommended. For children with asthma or elderly individuals with respiratory disease, remediation — when done promptly and thoroughly — is generally sufficient without requiring relocation, though severity of the infestation and the person’s health status should guide the decision in consultation with a physician.
Can a healthy adult become high-risk over time from mold exposure?
Yes, in two ways. First, prolonged low-level exposure can lead to allergic sensitization — a process in which the immune system becomes reactive to mold antigens and subsequently responds with symptoms to exposures that previously caused none. Second, development of asthma, whether mold-related or not, moves a previously low-risk individual into a higher-risk category for future mold exposure impacts.
